Ocular Therapeutix OCUL Market capitalization

Market capitalization at other companies

Regeneron PharmaceuticalsREGN

$65.37B+15.9%

EyePoint, Inc.EYPT

$1.2B+89.8%

KLR

Kalaris TherapeuticsKLRS

$132.3M—

Bausch + LombBLCO

$5.9B+38.8%

HRO

HarrowHROW

$1.31B+38.4%

Tarsus Pharmaceuticals, Inc.TARS

$2.71B+55.7%

FAQ

What is Ocular Therapeutix's market capitalization?

Ocular Therapeutix (OCUL) reported market capitalization of $1.84B in Q1 2026.

How has Ocular Therapeutix's market capitalization changed year-over-year?

Ocular Therapeutix's market capitalization increased by 58.2% year-over-year, from $1.17B to $1.84B.

What is the long-term trend for Ocular Therapeutix's market capitalization?

Over 5 years (2020 to 2025), Ocular Therapeutix's market capitalization has grown at a 10.3% compound annual growth rate (CAGR), from $1.59B to $2.59B.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.